Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumi Higuchi

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
World Neurosurgery|October 3, 2024
Endoscopic Ventriculocisternostomy with Stent Placement for Trapped Temporal HornDaisuke Sato, Shota Tanaka, Masahiro Shin, et al.
International Journal of Radiation Oncology, Biology, Physics|July 23, 2003
Severe complications in advanced esophageal cancer treated with radiotherapy after intubation of esophageal stents: a questionnaire survey of the Japanese Society for Esophageal DiseasesYasumasa Nishimura, Kenji Nagata, Susumu Katano, et al.
Journal of Neuro-Oncology|July 30, 2021
Gene expression profiling of 19q-loss astrocytomas suggest a specific pattern associated with the better prognosisRyohei Otani, Akitake Mukasa, Takeo Uzuka, et al.
Brain Tumor Pathology|January 31, 2024
Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatmentFumi Higuchi, Takeo Uzuka, Hadzki Matsuda, et al.
Molecular Cancer Therapeutics|September 16, 2018
PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency-Mediated Acquired Resistance to TemozolomideFumi Higuchi, Alexandria L Fink, Juri Kiyokawa, et al.
Cancer Science|May 13, 2018
IDH-mutated astrocytomas with 19q-loss constitute a subgroup that confers better prognosisRyohei Otani, Takeo Uzuka, Fumi Higuchi, et al.
Cancers|April 13, 2023
Efficacy of a Novel Augmented Reality Navigation System Using 3D Computer Graphic Modeling in Endoscopic Transsphenoidal Surgery for Sellar and Parasellar TumorsYoshiaki Goto, Ai Kawaguchi, Yuki Inoue, et al.
Cancer Discovery|July 2, 2020
Poly(ADP-ribose) Glycohydrolase Inhibition Sequesters NAD<sup>+</sup> to Potentiate the Metabolic Lethality of Alkylating Chemotherapy in IDH-Mutant Tumor CellsHiroaki Nagashima, Christine K Lee, Kensuke Tateishi, et al.
BMC Cancer|June 4, 2017
A nationwide multi-institutional retrospective study to identify prognostic factors and develop a graded prognostic assessment system for patients with brain metastases from uterine corpus and cervical cancerNakamasa Hayashi, Hideaki Takahashi, Yuzo Hasegawa, et al.
Cancer Research|June 20, 2017
The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in <i>IDH1</i>-Mutant Cancers and Potentiates NAD<sup>+</sup> Depletion-Mediated CytotoxicityKensuke Tateishi, Fumi Higuchi, Julie J Miller, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
World Neurosurgery|October 3, 2024
Endoscopic Ventriculocisternostomy with Stent Placement for Trapped Temporal HornDaisuke Sato, Shota Tanaka, Masahiro Shin, et al.
International Journal of Radiation Oncology, Biology, Physics|July 23, 2003
Severe complications in advanced esophageal cancer treated with radiotherapy after intubation of esophageal stents: a questionnaire survey of the Japanese Society for Esophageal DiseasesYasumasa Nishimura, Kenji Nagata, Susumu Katano, et al.
Journal of Neuro-Oncology|July 30, 2021
Gene expression profiling of 19q-loss astrocytomas suggest a specific pattern associated with the better prognosisRyohei Otani, Akitake Mukasa, Takeo Uzuka, et al.
Brain Tumor Pathology|January 31, 2024
Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatmentFumi Higuchi, Takeo Uzuka, Hadzki Matsuda, et al.
Molecular Cancer Therapeutics|September 16, 2018
PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency-Mediated Acquired Resistance to TemozolomideFumi Higuchi, Alexandria L Fink, Juri Kiyokawa, et al.
Cancer Science|May 13, 2018
IDH-mutated astrocytomas with 19q-loss constitute a subgroup that confers better prognosisRyohei Otani, Takeo Uzuka, Fumi Higuchi, et al.
Cancers|April 13, 2023
Efficacy of a Novel Augmented Reality Navigation System Using 3D Computer Graphic Modeling in Endoscopic Transsphenoidal Surgery for Sellar and Parasellar TumorsYoshiaki Goto, Ai Kawaguchi, Yuki Inoue, et al.
Cancer Discovery|July 2, 2020
Poly(ADP-ribose) Glycohydrolase Inhibition Sequesters NAD<sup>+</sup> to Potentiate the Metabolic Lethality of Alkylating Chemotherapy in IDH-Mutant Tumor CellsHiroaki Nagashima, Christine K Lee, Kensuke Tateishi, et al.
BMC Cancer|June 4, 2017
A nationwide multi-institutional retrospective study to identify prognostic factors and develop a graded prognostic assessment system for patients with brain metastases from uterine corpus and cervical cancerNakamasa Hayashi, Hideaki Takahashi, Yuzo Hasegawa, et al.
Cancer Research|June 20, 2017
The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in <i>IDH1</i>-Mutant Cancers and Potentiates NAD<sup>+</sup> Depletion-Mediated CytotoxicityKensuke Tateishi, Fumi Higuchi, Julie J Miller, et al.
Pageof 4